Ms. Elizabeth Vandenbogaart is a Los Angeles, California based nurse practitioner. Her current practice location is Ucla 100 Medical Plz, Suite 630e, Los Angeles. Patients can reach her at 310-825-8816 or can fax her at 310-825-9013. Ms. Elizabeth Vandenbogaart is N.P. and her NPI number (Unique professional ID assigned by NPPES) is 1710228093. Ms. Elizabeth Vandenbogaart has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Ms. Elizabeth Vandenbogaart speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Ms. Elizabeth Vandenbogaart
Specialization:
Nurse Practitioner (NP)
Gender:
Female
Credentials:
N.P.
Practice Address:
Ucla 100 Medical Plz, Suite 630e, Los Angeles, California, 90095-7368
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1710228093
NPI Enumeration Date:
11 Mar, 2013
NPI Last Update On:
11 Mar, 2013
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Ms. Elizabeth Vandenbogaart Ucla 100 Medical Plz, Suite 630e Los Angeles, California
Zip:
90095-7368
Phone Number:
310-825-8816
Fax Number:
310-825-9013
Patients can reach Ms. Elizabeth Vandenbogaart at Ucla 100 Medical Plz, Suite 630e, Los Angeles, California or can call to book an appointment on 310-825-8816.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.